Todos Medical aims to develop and bring to market its revolutionary blood tests for detecting biomarkers of cancer (lat. Carcinoma). The company is spinoff of Ben-Gurion University (BGUni). Their new cancer test will add a layer to currently available cancer screening and diagnostics. The goal is to help save lives through early detection while being minimally invasive to the patient. Todos Medical’s vision is to become the standard of care in the way people are routinely checked for cancer (early detection). The new method is easy to implement and at a low cost, currently targeting the mass population as the first choice for cancer detection. The technology is a platform, and scientists are investigating methods for using the platform on other types of cancers. As a start scientists are focused on breast and colon cancers.